封面
市場調查報告書
商品編碼
1836796

全球非血管支架市場按應用、產品類型、材料類型和最終用戶分類—預測至 2025 年至 2032 年

Non-vascular Stents Market by Application, Product Type, Material Type, End User - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年非血管支架市場將成長至 23.1 億美元,複合年成長率為 7.47%。

主要市場統計數據
基準年2024年 13億美元
預計2025年 14億美元
預測年份:2032年 23.1億美元
複合年成長率(%) 7.47%

全面介紹非血管支架,重點在於臨床應用、技術發展以及影響各專業應用的策略促進因素

隨著臨床醫生和器械製造商應對日益增多的臨床適應症和不斷發展的手術標準,非血管支架已成為介入醫學的重要組成部分。這些器械可治療各種非血管腔內病變,提供機械支撐,維持通暢性,並支持在氣道、膽道、胃腸道和泌尿系統系統進行微創手術。隨著手術的日益複雜化、跨學科協作以及向門診病人和流動醫療環境的轉變,非血管支架的應用也隨之增加。在這些環境中,器械的性能和易用性對臨床工作流程和病患週轉量有重大影響。

近期的技術進步,包括合金冶金、聚合物塗層和輸送系統的改進,降低了併發症率並延長了器械的使用壽命。因此,越來越多的臨床醫生選擇支架進行複雜的解剖結構和可重複的干涉。同時,醫療保健系統也優先考慮能夠減少住院時間和再入院率的工具,因此產品價值的評判標準也擴大不僅取決於其直接的臨床效果,還取決於其對資源利用的下游影響。多個司法管轄區的監管途徑已經成熟,明確了市場准入和上市後監管的證據閾值,這反過來又影響著製造商的投資策略。

不斷變化的醫療模式和日益嚴格的付款人審查意味著公司必須將器械性能與清晰的健康經濟敘事相結合。擁有可靠臨床數據、精簡物流以及與採購相關人員進行戰術性互動的製造商將最有能力影響處方和操作指南。總而言之,非血管支架的前景由技術進步、跨專業操作的普及以及日益成長的將臨床價值與系統級結果相結合的需求所決定。

重大的技術、程序和循證轉變將重新定義非血管支架採用的設備設計、臨床路徑和採購優先級

近年來,醫療體系中非血管支架的設計、評估和部署再形成發生了變革性的變化。首先,材料創新已超越漸進式變革,能夠針對特定的解剖和病理情況提供客製化解決方案。合金工程和鎳鈦合金加工如今支持更高的徑向力和順應性,而聚合物材料則為生物整合和藥物輸送提供了替代策略,為輔助性治療開闢了新的可能性。

其次,微創技術在各專業的普及重塑了手術路徑。肺科、胃腸科和泌尿系統等專業擴大使用影像引導、內視鏡和混合方法,因此需要最佳化輸送系統以提高精準度並減少創傷。因此,器械設計也更以使用者為中心,強調易於實施、縮短手術時間以及與現有手術設施的兼容性。

第三,醫療保健服務模式正轉向門診和門診,在這些情況下,吞吐量和可預測的結果決定了購買決策。這種轉變迫使製造商改善滅菌、包裝和物流,以滿足門診手術中心的要求。最後,真實世界證據正在加速將真實世界證據納入監管和付款人對話。真實世界註冊和實用研究正在補充對照試驗,以展示比較表現和經濟影響,為臨床醫生的偏好和報銷討論提供資訊。總而言之,這些轉變表明,未來的競爭力將取決於將臨床有效性、營運效率和可證明的經濟價值相結合的綜合解決方案。

2025 年的關稅將如何重塑供應鏈、製造地和採購行為,並對醫療設備經濟和准入產生長期影響?

2025年美國關稅的徵收和提高,將對非血管支架製造商、經銷商和臨床服務提供者產生一系列複雜的下游影響。關稅政策給進口原料和成品器械帶來了額外的成本壓力,並波及到供應鏈談判、庫存策略以及與醫療保健系統的定價談判。重要的是,關稅已促使許多公司重新評估供應商多元化和近岸外包作為穩定投入成本和前置作業時間的機制。

為了因應關稅帶來的成本變化,製造商採取了多種戰術性應對措施。一些製造商加快了製造和組裝的本地化進程,以減輕進口關稅的影響;其他製造商則探索了關稅分類和合規策略,以限制關稅負擔。這些選擇會影響資本配置和位置選擇,以及監理備案和品質體系協調。經銷商和醫院正在調整採購順序,增加安全庫存,並延長合約談判,以納入保護利潤和業務連續性的關稅應急條款。

除了直接的財務影響之外,關稅也改變了競爭動態。擁有一體化本地供應鏈的國內製造商在某些產品類型中獲得了相對價格優勢,這使得它們能夠更積極地與大型醫療系統簽訂合約。相反,依賴全球採購的小型供應商面臨利潤率壓縮,導致它們優先考慮更高價值的SKU和策略夥伴關係。在臨床方面,採購相關人員正在加強對醫療總成本(而不僅僅是單位成本)的審查,並要求生命週期成本、再干涉率和服務合約的透明度。整體而言,2025年的關稅環境正在推動供應鏈重組,影響策略投資決策,並提升彈性採購和差異化價值提案的重要性。

策略性細分洞察,將臨床應用、產品類型、材料和最終用戶動態映射到可操作的商業化優先事項

對於尋求將產品開發和商業策略與臨床實際情況相結合的相關人員來說,細緻入微地理解細分市場至關重要。按應用分析,市場涵蓋呼吸道、膽道、胃腸道和泌尿系統道,其中呼吸道細分市場進一步細分為支氣管和氣管管段,胃腸道細分市場進一步細分為結腸、十二指腸和食道應用。泌尿系統同樣分為前列腺、輸尿管和尿道應用,每種應用都有不同的解剖挑戰、臨床終點和手術流程,進而影響器械的幾何形狀、徑向強度和輸送機制。

產品類型區分球囊擴張型和自擴張型,這決定了部署技術、輔助成像需求以及與彎曲或動態管腔的兼容性。鎳鈦合金具有超彈性和順應性,聚合物具有生物分解特性和藥物釋放型機會,不銹鋼則具有傳統的性能特徵和成本優勢。最終用戶細分區分了門診手術中心和醫院,這對包裝、滅菌標準、存貨周轉和銷售管道參與度具有戰略意義。

綜上所述,這些細分領域構成了一個由臨床、營運和商業性變數組成的矩陣,企業必須應對這些變數。產品團隊必須將器械規格與特定的解剖和手術需求相匹配,而商業領導者則必須根據門診和住院採購環境的實際情況,客製化通訊和定價。此外,研發優先順序必須在材料創新與法規可追溯性和製造擴充性之間取得平衡,以確保新產品能夠滿足不同的臨床需求和系統級需求。

應對部署非血管支架的主要全球市場的監管複雜性、採購行為和臨床多樣性的區域策略

區域動態對監管途徑、採購行為和臨床應用模式有著重大影響,因此需要在全球市場制定差異化策略。美洲地區呈現出一個多元化的環境,先進的臨床能力和多樣化的付款人模式並存。監管期望強調臨床證據以支持上市後監督和報銷談判,而採購決策通常由機構層級的委員會和基於價值的合約安排驅動。

在歐洲、中東和非洲,相關人員面臨著錯綜複雜的國家法規結構和預算壓力,這些因素凸顯了成本效益和結果數據的重要性。亞太地區融合了先進的醫療保健系統和快速崛起的市場,需求多種多樣,從高複雜性的設備需求到成本敏感型解決方案,以及支援區域生產和分銷策略的製造生態系統和供應鏈節點。

這些地區共同挑戰製造商,他們需要在全球生命週期管理與區域特定情報之間取得平衡。上市計劃必須納入監管時機、報銷途徑以及反映當地臨床實踐和採購文化的策略夥伴關係關係。此外,供應鏈設計和商業模式必須適應區域物流、製造能力和醫療保健系統的優先事項,以確保在不同地區實現永續的採用和可擴展的成長。

競爭格局分析揭示了現有企業、專業創新者和區域參與企業如何在臨床證據、物流和商業模式方面競爭

非血管支架市場的競爭動態反映出現有醫療設備公司、專業創新企業和新興區域企業的混合,它們各自尋求不同的臨床應用和市場滲透路徑。現有企業專注於整合的產品組合、強大的分銷網路,以及將器械與服務和培訓項目捆綁銷售的能力,從而減少手術差異並促進臨床醫生的採用。這些現有企業通常會投資長期證據產生和指引參與,以鞏固臨床偏好。

相較之下,專業創新者瞄準的是利基解剖或手術挑戰,並專注於技術差異化,例如新型材料科學、混合藥物-器械組合以及針對複雜幾何形狀最佳化的輸送系統。這類公司經常利用早期臨床合作夥伴關係和研究者主導的臨床實驗來檢驗產品效能,並獲得關鍵意見領袖的支持。區域製造商和新參與企業在成本和本地監管靈活性方面展開競爭,在成本敏感型市場提供可行的替代方案,並利用與區域供應鏈的便利性來縮短前置作業時間。

無論競爭如何,成功的公司都會將臨床開發與清晰的經濟敘事相結合,並引起醫院管理者和門診手術中心的共鳴。此外,通路策略至關重要。直銷模式可以促進更緊密的臨床醫生參與和上市後支持,而分銷商夥伴關係則可以在分散的市場中加速覆蓋。最終,那些兼具臨床信譽、供應鏈韌性以及針對目標細分市場診療流程和採購實際情況的商業模式的公司將獲得競爭優勢。

製造商應優先採取的行動包括確保臨床可靠性、加強供應鏈,並使商業策略與不斷發展的醫療保健服務模式保持一致

產業領導者必須果斷行動,將技術潛力轉化為永續的市場地位。首先,製造商應優先制定符合付款方和監管機構期望的臨床證據策略,並投資於可操作的註冊研究和現實世界研究,以證明其在再介入、住院時間和整體手術成本方面取得了顯著降低。這些證據將有助於醫院處方集的納入和基於價值的合約談判。

其次,應將供應鏈韌性提升至策略重點。企業應實現採購多元化,考慮關鍵零件近岸外包,並制定能夠應對關稅波動和物流中斷的庫存策略。同時,商業團隊應針對門診手術中心和醫院量身市場開發方法,客製化服務產品、培訓計畫和產品包裝,以應對不同的營運限制。投資臨床醫生教育和流程標準化可以減少差異性並加速採用。

第三,產品藍圖應在材料創新與可製造性和法規可追溯性之間取得平衡,優先考慮能夠彌補明確流程差距的增量臨床效益。研發、法規和商業團隊之間的跨職能協作可以加快產品上市時間並確保市場相關性。最後,領導者應探索策略夥伴關係和選擇性併購,以增強在藥物釋放型技術、聚合物科學或區域製造方面的能力。執行這些優先事項將使公司能夠在競爭日益激烈的環境中建立差異化並保持成長。

嚴格的混合方法研究方法結合了臨床醫生訪談、監管和臨床證據綜合以及供應鏈分析,確保了可操作和檢驗的見解

本研究整合了主要和次要研究,包括臨床文獻、監管申報、器械註冊和相關人員訪談,旨在全面了解非血管支架的市場格局。主要研究包括對介入臨床醫生、採購負責人和監管專家的結構化訪談,以了解手術趨勢、證據預期和購買行為。這些定性見解與臨床試驗數據、同行評審出版物和公開的監管文件進行了三角檢驗,以確認技術準確性和臨床相關性。

二級資訊來源包括製造商產品資訊、器械附加檔說明書以及專業協會指南,以闡明器械特性和建議用法。透過進出口數據、材料採購報告以及與物流供應商的訪談,分析了供應鏈和製造方面的洞察,以評估其脆弱性和營運策略。分析方法包括定性資料的主題編碼、跨多項研究的臨床結果交叉檢驗以及情境分析,以評估關稅和供應鏈突發事件。為了保持調查方法的嚴謹性並與決策者相關,關鍵研究結果由專家檢驗,以確保與臨床實際情況和商業性影響相符。

全面回顧這些結論,強調了技術創新、證據生成和營運彈性的整合,這將決定非血管支架相關人員的長期成功。

非血管支架正在從一系列獨立的器械類別轉變為一個互聯互通的領域,材料科學、輸送技術和醫療保健系統優先事項的交匯決定了其臨床和商業性成功。該市場的特點是越來越重視可證實的患者療效、門診和醫院的營運效率,以及能夠承受地緣政治和關稅相關壓力的靈活供應鏈。這些因素將為那些將可靠的臨床證據與務實的生產和分銷策略相結合的組織帶來回報。

展望未來,針對特定解剖挑戰的差異化材料和以用戶為中心的輸送系統的競爭將愈演愈烈,而監管和支付方格局將優先考慮實際性能和成本效益。積極將研發投資與報銷要求相結合,並建立夥伴關係關係以擴大臨床檢驗的組織將塑造實踐模式和採購選擇。最終,非血管支架領域的成功將取決於能否將創新轉化為可衡量的系統級價值,並執行能夠滿足臨床醫生、患者和醫療保健系統買家需求的彈性商業化策略。

目錄

第1章:前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 開發生物可吸收聚合物氣管支架以減少長期併發症
  • 將藥物釋放型技術整合到氣道支架中,以最大限度地減少肉芽組織的形成
  • 利用 3D 列印技術製作患者專用食道支架,解決複雜的解剖變異
  • 形狀記憶合金氣管支架的進步提高了部署的準確性和一致性
  • 泌尿系統支架抗菌塗層的投資正在增加,以對抗生物膜相關感染疾病
  • 下一代消化器官系統產品 CE 標誌監管進展加速市場進入

第6章:2025年美國關稅的累積影響

第7章:人工智慧的累積影響,2025年

8. 非血管支架市場(依應用)

  • 呼吸道
    • 支氣管
    • 氣管
  • 膽汁
  • 消化器官系統
    • 冒號
    • 十二指腸
    • 食道
  • 泌尿系統
    • 攝護腺
    • 輸尿管
    • 尿道

9. 非血管支架市場(依產品類型)

  • 球囊擴張
  • 自膨脹

第 10 章非血管支架市場(依材料類型)

  • 鎳鈦合金
  • 聚合物
  • 不銹鋼

第 11 章非血管支架市場(依最終用戶)

  • 門診手術中心
  • 醫院

12. 非血管支架市場(按地區)

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章非血管支架市場(依類別)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 非血管支架市場(依國家)

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Cook Medical LLC
    • B. Braun Melsungen AG
    • Merit Medical Systems, Inc.
    • Teleflex Incorporated
    • Endo International plc
    • Taewoong Medical Co., Ltd.
Product Code: MRR-036C5CF3B534

The Non-vascular Stents Market is projected to grow by USD 2.31 billion at a CAGR of 7.47% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.30 billion
Estimated Year [2025] USD 1.40 billion
Forecast Year [2032] USD 2.31 billion
CAGR (%) 7.47%

A comprehensive orientation to non-vascular stents highlighting clinical breadth, technological evolution, and the strategic drivers shaping adoption across specialties

Non-vascular stents now occupy a pivotal role in interventional medicine as clinicians and device manufacturers respond to expanding clinical indications and evolving procedural standards. These devices address an array of luminal pathologies beyond the vascular system, providing mechanical support, maintaining patency, and enabling minimally invasive approaches across airway, biliary, gastrointestinal, and urological domains. Adoption is driven by increasing procedural sophistication, cross-specialty collaboration, and a shift toward outpatient and ambulatory care settings where device performance and ease of deployment materially affect clinical workflow and patient throughput.

Recent technological refinements, such as improvements in alloy metallurgy, polymer coatings, and delivery systems, have reduced complication rates and improved device longevity. As a result, clinicians are more willing to select stents for complex anatomies and repeatable interventions. Concurrently, health systems are prioritizing tools that reduce length of stay and rehospitalization, so product value is judged not only by immediate clinical efficacy but also by impact on downstream resource utilization. Regulatory pathways have matured in several jurisdictions, clarifying evidence thresholds for market access and post-market surveillance, which in turn shapes manufacturer investment strategies.

Transitioning care models and intensifying scrutiny from payers mean that companies must align device performance with clear health economic narratives. Manufacturers who combine robust clinical data with streamlined logistics and tactical engagement with procurement stakeholders will be best positioned to influence formularies and procedural guidelines. In sum, the non-vascular stents landscape is defined by technical progress, procedural diffusion across specialties, and the increasing necessity of aligning clinical value with system-level outcomes.

Major technological, procedural, and evidence-based shifts that are redefining device design, clinical pathways, and procurement priorities in non-vascular stent adoption

The recent period has witnessed transformative shifts reshaping how non-vascular stents are designed, evaluated, and deployed within health systems. First, material innovation has progressed beyond incremental changes to enable purpose-built solutions for specific anatomical and pathological contexts. Alloy engineering and nitinol processing now support enhanced radial force and conformability while polymeric materials offer alternative strategies for biointegration and drug delivery, opening new opportunities for adjunctive therapies.

Second, procedural pathways have realigned as minimally invasive techniques proliferate across specialties. Interventional pulmonology, gastroenterology, and urology increasingly adopt image-guided, endoscopic, and combined hybrid approaches, which in turn demand delivery systems optimized for precision and reduced trauma. Consequently, device design has become more user-centric, focusing on ease of deployment, reduced procedure time, and compatibility with existing procedural suites.

Third, healthcare delivery models are shifting care toward ambulatory and outpatient settings where throughput and predictable outcomes drive purchasing decisions. This shift compels manufacturers to refine sterilization, packaging, and logistics to meet ambulatory surgical center requirements. Lastly, the integration of real-world evidence into regulatory and payer conversations has accelerated. Real-world registries and pragmatic studies now supplement controlled trials to demonstrate comparative performance and economic impact, informing clinician preference and reimbursement discussions. Collectively, these shifts emphasize that future competitiveness will depend on integrated solutions that combine clinical efficacy, operational efficiency, and demonstrable economic value.

How 2025 tariff measures are reshaping supply chains, manufacturing footprints, and procurement behaviors with long-term implications for device economics and access

The imposition and escalation of tariffs by the United States in 2025 have created a complex set of downstream effects for manufacturers, distributors, and clinical providers engaged with non-vascular stents. Tariff policy has introduced incremental cost pressures on imported raw materials and finished devices, which in turn reverberate through supply chain negotiations, inventory strategies, and pricing conversations with health systems. Importantly, tariffs have also prompted many organizations to re-evaluate supplier diversity and nearshoring as mechanisms to stabilize input costs and lead times.

In response to tariff-driven cost volatility, manufacturers have pursued several tactical responses. Some have accelerated localization of manufacturing and assembly operations to mitigate exposure to import duties, while others have sought tariff classifications and compliance strategies to limit duty burdens. These choices affect capital allocation and site selection, with implications for regulatory filings and quality system harmonization. Distributors and hospitals have adjusted procurement cadence, increasing safety stock and extending contract negotiations to incorporate tariff contingency clauses that protect margins and operational continuity.

Beyond direct financial effects, tariffs have shifted competitive dynamics. Domestic producers with integrated local supply chains have gained relative pricing advantage in certain product categories, enabling more aggressive contracting with large health systems. Conversely, smaller suppliers reliant on global sourcing have faced compressed margins and have prioritized higher-value SKUs or strategic partnerships. On the clinical side, purchasing stakeholders have heightened scrutiny of total cost of care rather than unit price alone, seeking transparency on lifecycle costs, reintervention rates, and service agreements. Overall, the tariff environment in 2025 has catalyzed supply chain reconfiguration, influenced strategic investment decisions, and increased the importance of resilient sourcing and differentiated value propositions.

Strategic segmentation insights that map clinical applications, product types, materials, and end-user dynamics to actionable commercialization priorities

A nuanced understanding of segmentation is essential for stakeholders seeking to align product development and commercial strategies with clinical realities. When analyzed by application, the market spans airway, biliary, gastrointestinal, and urological indications, with the airway category further disaggregated into bronchial and tracheal subsegments and the gastrointestinal category further parsed into colorectal, duodenal, and esophageal uses. The urological domain likewise differentiates into prostatic, ureteral, and urethral applications, each presenting distinct anatomical challenges, clinical endpoints, and procedural workflows that influence device geometry, radial strength, and delivery mechanisms.

Product type delineation separates balloon-expandable devices from self-expanding constructs, a distinction that informs deployment technique, requirement for adjunctive imaging, and suitability for tortuous or dynamic lumens. Material type remains a foundational axis of differentiation, as nitinol imparts superelasticity and conformability, polymeric solutions offer alternative biodegradation profiles and drug elution opportunities, and stainless steel provides legacy performance characteristics and cost considerations. End-user segmentation distinguishes ambulatory surgical centers from hospitals, and this distinction carries strategic implications for packaging, sterilization standards, inventory turnover, and sales channel engagement.

Taken together, these segmentation lenses produce a matrix of clinical, operational, and commercial variables that companies must navigate. Product teams should map device specifications to specific anatomical and procedural needs, while commercial leaders must tailor messaging and pricing to the procurement realities of ambulatory versus inpatient settings. In addition, R&D prioritization should balance material innovations with regulatory tractability and manufacturing scalability to ensure that new offerings address discrete clinical gaps and system-level requirements.

Regional strategies that reconcile regulatory complexity, procurement behaviors, and clinical diversity across major global markets for non-vascular stent deployment

Regional dynamics exert a profound influence on regulatory pathways, procurement behavior, and clinical adoption patterns, requiring differentiated strategies across global markets. The Americas region presents a heterogeneous environment where advanced clinical capabilities coexist with diverse payer models; regulatory expectations emphasize post-market surveillance and clinical evidence that supports reimbursement negotiations, while procurement decisions often hinge on institution-level committees and value-based contracting arrangements.

In Europe, Middle East & Africa, stakeholders encounter a mosaic of national regulatory frameworks and budgetary pressures that elevate the importance of cost-effectiveness and outcomes data; localized clinical practice variations and national procurement policies necessitate tailored market access approaches and country-level evidence generation. Asia-Pacific encompasses both advanced healthcare systems and rapidly developing markets, yielding a spectrum of needs from high-complexity device demand to cost-sensitive solutions, with manufacturing ecosystems and supply chain nodes that can support regional production and distribution strategies.

Collectively, these regions demand that manufacturers balance global lifecycle management with localized intelligence. Market entry plans should incorporate regulatory timing, reimbursement pathways, and strategic partnerships that reflect regional clinical practice and procurement culture. Moreover, supply chain design and commercial models must adapt to regional logistics, manufacturing capabilities, and health system priorities to ensure sustainable adoption and scalable growth across distinct geographic contexts.

Competitive landscape analysis revealing how incumbents, specialized innovators, and regional entrants compete on clinical evidence, logistics, and commercial models

Competitive dynamics in the non-vascular stents space reflect a mix of established medical device firms, specialized innovators, and emerging regional players, each pursuing different pathways to clinical adoption and market penetration. Established firms emphasize integrated portfolios, robust distribution networks, and the ability to bundle devices with service offerings and training programs that reduce procedural variability and accelerate clinician uptake. These incumbents often invest in long-term evidence generation and guideline engagement to solidify clinical preference.

Specialized innovators, by contrast, target niche anatomical or procedural challenges with focused technological differentiation-such as novel material science, hybrid drug-device combinations, or delivery systems optimized for complex geometries. These firms frequently leverage early clinical partnerships and investigator-initiated studies to validate performance and to build key opinion leader support. Regional manufacturers and new entrants compete on cost and local regulatory agility, offering pragmatic alternatives in cost-sensitive markets and exploiting proximity to regional supply chains to shorten lead times.

Across competitor types, successful companies align clinical development with clear economic narratives that speak to hospital administrators and ambulatory surgical centers alike. Additionally, channel strategy matters: direct sales models can foster closer clinician engagement and post-market support, while distributor partnerships can accelerate reach in fragmented markets. Ultimately, competitive advantage will accrue to organizations that combine clinical credibility, supply chain resilience, and commercial models tailored to the procedural and procurement realities of their target segments.

Actionable priorities for manufacturers to secure clinical credibility, strengthen supply chains, and align commercial strategies with evolving care delivery models

Industry leaders must act decisively to convert technological promise into durable market positions while mitigating operational and regulatory risks. First, manufacturers should prioritize clinical evidence strategies that align with payer and regulatory expectations, investing in pragmatic registries and real-world studies that demonstrate meaningful reductions in reintervention, length of stay, and overall procedural cost. This evidence will support both hospital formulary inclusion and value-based contracting conversations.

Second, supply chain resilience should be elevated to a strategic priority. Companies ought to diversify sourcing, consider nearshoring for critical components, and build inventory strategies that account for tariff volatility and logistics disruptions. Concurrently, commercial teams must tailor go-to-market approaches for ambulatory surgical centers and hospitals, customizing service offerings, training programs, and packaging to meet differing operational constraints. Investing in clinician education and procedural standardization will reduce variability and accelerate adoption.

Third, product roadmaps should balance material innovation with manufacturability and regulatory tractability, favoring incremental clinical gains that address well-defined procedural gaps. Cross-functional alignment among R&D, regulatory, and commercial teams will accelerate time-to-market and ensure market-fit. Finally, leaders should explore strategic partnerships and selective M&A to expand capabilities in drug-eluting technologies, polymer science, or regional manufacturing capacity. By executing on these priorities, companies can create defensible differentiation and sustain growth in an increasingly competitive landscape.

Rigorous mixed-method research approach combining clinician interviews, regulatory and clinical evidence synthesis, and supply chain analysis to ensure actionable and validated insights

This research synthesizes primary and secondary inputs across clinical literature, regulatory filings, device registries, and stakeholder interviews to construct a comprehensive view of the non-vascular stents landscape. Primary research included structured interviews with interventional clinicians, procurement leaders, and regulatory experts to capture procedural trends, evidence expectations, and purchasing behaviors. These qualitative insights were triangulated with analyses of clinical trial data, peer-reviewed publications, and publicly available regulatory documents to ensure technical accuracy and clinical relevance.

Secondary sources encompassed manufacturer product information, device labeling, and professional society guidelines to contextualize device features and recommended usage. Supply chain and manufacturing considerations were analyzed through import/export data, materials sourcing reports, and interviews with logistics providers to assess vulnerabilities and operational strategies. Analytical methods included thematic coding of qualitative data, cross-validation of clinical outcomes from multiple studies, and scenario analysis to evaluate tariff and supply chain contingencies. Throughout, an iterative review process ensured alignment between clinical realities and commercial implications, and subject-matter experts validated key findings to maintain methodological rigor and relevance for decision-makers.

Concluding synthesis highlighting the convergence of innovation, evidence generation, and operational resilience that will determine long-term success for non-vascular stent stakeholders

Non-vascular stents are transitioning from a set of discrete device categories into an interconnected domain where material science, delivery technology, and health system priorities intersect to determine clinical and commercial success. The market is characterized by heightened emphasis on demonstrable patient outcomes, operational efficiency in ambulatory and hospital settings, and adaptive supply chains that can withstand geopolitical and tariff-related pressures. These forces will reward organizations that integrate robust clinical evidence with pragmatic manufacturing and distribution strategies.

Looking forward, competition will intensify around differentiated materials and user-centric delivery systems that address specific anatomical challenges, while regulatory and payer landscapes will prioritize real-world performance and cost-effectiveness. Organizations that proactively align R&D investment with reimbursement imperatives and that cultivate partnerships to extend clinical validation will shape practice patterns and procurement choices. In conclusion, success in the non-vascular stents domain will hinge on the ability to translate technical innovation into measurable system-level value and to execute resilient commercialization strategies that meet the needs of clinicians, patients, and health system buyers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing development of bioresorbable polymer tracheal stents to reduce long-term complications
  • 5.2. Integration of drug-eluting technology in airway stents to minimize granulation tissue formation
  • 5.3. Use of 3D printing for patient-specific esophageal stents addressing complex anatomical variations
  • 5.4. Advancements in shape-memory alloy tracheal stents improving deployment precision and conformability
  • 5.5. Growing investment in antimicrobial coatings on urological stents to combat biofilm-associated infections
  • 5.6. Regulatory progress in CE marking of next-generation gastrointestinal non-vascular stents enabling faster market access

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-vascular Stents Market, by Application

  • 8.1. Airway
    • 8.1.1. Bronchial
    • 8.1.2. Tracheal
  • 8.2. Biliary
  • 8.3. Gastrointestinal
    • 8.3.1. Colorectal
    • 8.3.2. Duodenal
    • 8.3.3. Esophageal
  • 8.4. Urological
    • 8.4.1. Prostatic
    • 8.4.2. Ureteral
    • 8.4.3. Urethral

9. Non-vascular Stents Market, by Product Type

  • 9.1. Balloon-Expandable
  • 9.2. Self-Expanding

10. Non-vascular Stents Market, by Material Type

  • 10.1. Nitinol
  • 10.2. Polymeric
  • 10.3. Stainless Steel

11. Non-vascular Stents Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospitals

12. Non-vascular Stents Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Non-vascular Stents Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-vascular Stents Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Medtronic plc
    • 15.3.3. Abbott Laboratories
    • 15.3.4. Becton, Dickinson and Company
    • 15.3.5. Cook Medical LLC
    • 15.3.6. B. Braun Melsungen AG
    • 15.3.7. Merit Medical Systems, Inc.
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. Endo International plc
    • 15.3.10. Taewoong Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NON-VASCULAR STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NON-VASCULAR STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NON-VASCULAR STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NON-VASCULAR STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BRONCHIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY TRACHEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BILIARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY COLORECTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY DUODENAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY ESOPHAGEAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PROSTATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETERAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY URETHRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY BALLOON-EXPANDABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY SELF-EXPANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY POLYMERIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NON-VASCULAR STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. GCC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. GCC NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. GCC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 288. GCC NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 289. GCC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 290. GCC NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 291. GCC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. GCC NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. GCC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. GCC NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. GCC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. GCC NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS NON-VASCULAR STENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. G7 NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. G7 NON-VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. G7 NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 332. G7 NON-VASCULAR STENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 333. G7 NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 NON-VASCULAR STENTS MARKET SIZE, BY AIRWAY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
  • TABLE 336. G7 NON-VASCULAR STENTS MARKET SIZE, BY GASTROINTESTINAL, 2025-2032 (USD MILLION)
  • TABLE 337. G7 NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2018-2024 (USD MILLION)
  • TABLE 338. G7 NON-VASCULAR STENTS MARKET SIZE, BY UROLOGICAL, 2025-2032 (USD MILLION)
  • TABLE 339. G7 NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. G7 NON-VASCULAR STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. G7 NON-VASCULAR STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 342. G7 NON-VASCULAR STENTS MARKET SIZE, BY MATERIA